Activation of ERK during ischemia-reperfusion in lung transplantation.

肺移植缺血再灌注过程中 ERK 的激活。

基本信息

  • 批准号:
    14571268
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

1.Experiment in a rat lung transplant model.Dramatic alterations of protein tyrosine phosphorylation have been found during the ischemia-reperfusion period of human lung transplantation. The object of the present study was to determine whether these changes exist in a rat single-lung transplant model. Lung transplantations were performed after 6 hours of cold ischemic preservation. In both iso-and allografts, the lung function of transplants was very well preserved. Protein tyrosine phosphorylation, protein tyrosine kinase and protein tyrosine phosphatase activities were decreased significantly after 2 hours of reperfusion. Src protein level and phosphorylation of p38 were reduced after 2 hours of reperfusion. This lung transplantation model is useful for studying ischemia-reperfusion injury.MAPK activation in human lung transplantThe phosphorylation status of MAPK during ischemia-reperfusion in human lung transplant was examined. These transplantations were performed in Toronto General Hospital in Canada. Lung tissue biopsy was performed on 15 patients undergoing transplantation: after the cold ischemic preservation, after the warm ischemia (implantation) and after 1 h or 2 h reperfusion. The phosphorylation status of ERK, p38-MAPK, INK and MEK was examined with Western blotting. Phosphorylation of INK also significantly increased at lower levels. In contrast, phosphorylation of p38 had no significant changes. The increase in ERK phosphotylation was not associated with the activation of MEK, the up-stream kinase for ERK. Since MKP-3 protein levels correspond to its activity, we examined the protein expression of MKP-3 in these samples. Surprisingly, the MKP-3 protein level significantly increased after reperfusion. Therefore, the dramatic increase in ERK phosphorylation is not due to the inhibited expression of MKP-3.
1.大鼠肺移植模型实验。在人肺移植缺血再灌注期,蛋白酪氨酸磷酸化发生了显著变化。本研究的目的是确定这些变化是否存在于大鼠单肺移植模型中。冷缺血保存6小时后进行肺移植。在同种异体和同种异体移植中,移植的肺功能都得到了很好的保存。蛋白酪氨酸磷酸化、蛋白酪氨酸激酶和蛋白酪氨酸磷酸酶活性在再灌注2 h后显著降低。再灌注2小时后,Src蛋白水平和p38磷酸化水平降低。该肺移植模型可用于研究缺血再灌注损伤。研究MAPK在人肺移植缺血-再灌注过程中的磷酸化状态。这些移植是在加拿大多伦多总医院进行的。对15例移植患者分别在冷缺血保存后、热缺血(植入)后、再灌注1 h或2 h后进行肺组织活检。Western blotting检测ERK、p38-MAPK、INK和MEK的磷酸化状态。在较低水平下,INK的磷酸化也显著增加。相比之下,p38的磷酸化没有明显变化。ERK磷酸化的增加与ERK的上游激酶MEK的激活无关。由于MKP-3蛋白水平与其活性相对应,我们检测了这些样品中MKP-3蛋白的表达。令人惊讶的是,再灌注后MKP-3蛋白水平显著升高。因此,ERK磷酸化的急剧增加并不是因为MKP-3的表达受到抑制。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sakiyama S 他: "Ischemia-reperfusion decreases protein tyrosine phosphorylation and p38 mitogen-activated protein kinase phosphorylation in rat lung transplants"J Heart Lung Transplant. 22・3. 338-346 (2003)
Sakiyama S 等:“缺血再灌注降低大鼠肺移植中的蛋白质酪氨酸磷酸化和 p38 丝裂原激活蛋白激酶磷酸化”J Heart Lung Transplant 22・3 (2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sakiyama S, dePerrot M, Han B, Waddell TK, Keshavjee S, Liu M.: "Ischemia-reperfusion decreases protein tyrosine phosphorylation and p38 mitogen-activated protein kinase phosphorylation in rat lung transplants."J Heart Lung Transplant.. 22(3). 338-346 (20
Sakiyama S、dePerrot M、Han B、Waddell TK、Keshavjee S、Liu M.:“缺血再灌注会降低大鼠肺移植中的蛋白酪氨酸磷酸化和 p38 丝裂原激活蛋白激酶磷酸化。”J Heart Lung Transplant.. 22(3
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takehisa Y, Sakiyama S他: "Progressive increase of CD4(+)/CD45RC(-) lymphocytes after allograft rat lung transplantation : a marker of acute rejection"J Thorac Cardiovasc Surg. 124・4. 675-683 (2002)
Takehisa Y、Sakiyama S等:“同种异体移植大鼠肺移植后CD4(+)/CD45RC(-)淋巴细胞的进行性增加:急性排斥反应的标志”J Thorac Cardiovasc Surg. 124・4. )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takehisa Y, Sakiyama S他: "Progressive increase of CD4(+)/CD45RC(-) lymphocytes after allograft rat lung transplantation : a marker of acute rejection."J Thorac Cardiovasc Surg. 124. 675-683 (2002)
Takehisa Y、Sakiyama S 等:“同种异体大鼠肺移植后 CD4(+)/CD45RC(-) 淋巴细胞的逐渐增加:急性排斥反应的标志。”J Thorac Cardiovasc Surg. 124. 675-683 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takehisa Y, Sakiyama S, Uyama T, Sumitomo M, Tamaki M, Hino H, Takehisa M, Liu M, Kondo K, Monden Y.: "Progressive increase of CD4(+)/CD45RC(-) lymphocytes after allograft rat lung transplantation : a marker of acute rejection."J Thorac Cardiovase Surg..
Takehisa Y、Sakiyama S、Uyama T、Sumitomo M、Tamaki M、Hino H、Takehisa M、Liu M、Kondo K、Monden Y.:“同种异体大鼠肺移植后 CD4( )/CD45RC(-) 淋巴细胞逐渐增加:
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKIYAMA Shoji其他文献

SAKIYAMA Shoji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKIYAMA Shoji', 18)}}的其他基金

Fetal lung fragments implantation into fibrotic lung of a pig model
胎儿肺碎片植入猪模型纤维化肺中
  • 批准号:
    26462127
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Experimental examination of the pulmonary emphysema treatment with fetal lung tissues transplantation - a pig emphysema model -
胎肺组织移植治疗肺气肿的实验研究-猪肺气肿模型-
  • 批准号:
    23592062
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Implantation of fetal pig lung fragments into adult rat lung parenchyma-search for a possibility of transbronchial delivery with a bronchoscope-
将胎猪肺碎片植入成年大鼠肺实质-探索支气管镜经支气管分娩的可能性-
  • 批准号:
    20591672
  • 财政年份:
    2008
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
IMMUNOSUPPRESSION WITH ANTI-T CELL RECEPTOR V-BETA ANTIBODY IN LUNG TRANSPLANTATON
肺移植中抗 T 细胞受体 V-β 抗体的免疫抑制
  • 批准号:
    09671383
  • 财政年份:
    1997
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
  • 批准号:
    82371142
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
  • 批准号:
    81070041
  • 批准年份:
    2010
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

Development of new lung preservation methods focusing on cell death related to ischemia-reperfusion injury after lung transplantation
开发新的肺保存方法,重点关注肺移植后缺血再灌注损伤相关的细胞死亡
  • 批准号:
    21K20948
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of a treatment for ischemia-reperfusion injury after lung transplantation targeting novel cell death ferroptosis
针对新型细胞死亡铁死亡的肺移植后缺血再灌注损伤治疗方法的开发
  • 批准号:
    20K17744
  • 财政年份:
    2020
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Reduction of donor mononuclear phagocytes during ex vivo lung perfusion attenuates ischemia-reperfusion injury in a rat lung transplantation model
离体肺灌注过程中供体单核吞噬细胞的减少可减轻大鼠肺移植模型的缺血再灌注损伤
  • 批准号:
    19K09302
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel treatment strategy against ischemia reperfusion lung injury after lung transplantation via the inhibition of necroptosis.
通过抑制坏死性凋亡,开发针对肺移植后缺血再灌注肺损伤的新治疗策略。
  • 批准号:
    19K09303
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Protective effects of hepatocyte growth factor during ex vivo lung perfusion on ischemia-reperfusion injury in lung transplantation
离体肺灌注过程中肝细胞生长因子对肺移植缺血再灌注损伤的保护作用
  • 批准号:
    18K16416
  • 财政年份:
    2018
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Nrf2 plays a role in ischemia-reperfusion lung injury after lung transplantation
Nrf2在肺移植后缺血再灌注肺损伤中发挥作用
  • 批准号:
    17K10528
  • 财政年份:
    2017
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of antioxidative transcription factor Nrf2 in strategies to protect against ischemia-reperfusion injury after lung transplantation
抗氧化转录因子Nrf2在肺移植后缺血再灌注损伤保护策略中的作用
  • 批准号:
    26462120
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
High-throughput screening for therapeutics against ischemia-reperfusion-induced lung injury in lung transplantation
高通量筛选肺移植中缺血再灌注引起的肺损伤的治疗方法
  • 批准号:
    253221
  • 财政年份:
    2012
  • 资助金额:
    $ 2.18万
  • 项目类别:
Mechanism and inhibition of ischemia reperfusion injury after lung transplantation from donation after cardiac death
心脏死亡捐献肺移植后缺血再灌注损伤的机制及抑制
  • 批准号:
    23592063
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
basic research for ischemia reperfusion injury following lung transplantation using a mouse orthotropic lung transplant model
利用小鼠正交异性肺移植模型进行肺移植后缺血再灌注损伤的基础研究
  • 批准号:
    20790988
  • 财政年份:
    2008
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了